Rank-based predictors for response and prognosis of neoadjuvant taxane-anthracycline-based chemotherapy in breast cancer.
about
Identifying disease-associated pathways in one-phenotype data based on reversal gene expression orderings.Tamoxifen therapy benefit predictive signature coupled with prognostic signature of post-operative recurrent risk for early stage ER+ breast cancer.An individualized prognostic signature and multi‑omics distinction for early stage hepatocellular carcinoma patients with surgical resectionRobust transcriptional tumor signatures applicable to both formalin-fixed paraffin-embedded and fresh-frozen samples.Overexpression of ILK1 in breast cancer associates with poor prognosis.
P2860
Rank-based predictors for response and prognosis of neoadjuvant taxane-anthracycline-based chemotherapy in breast cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Rank-based predictors for resp ...... chemotherapy in breast cancer.
@en
Rank-based predictors for resp ...... chemotherapy in breast cancer.
@nl
type
label
Rank-based predictors for resp ...... chemotherapy in breast cancer.
@en
Rank-based predictors for resp ...... chemotherapy in breast cancer.
@nl
prefLabel
Rank-based predictors for resp ...... chemotherapy in breast cancer.
@en
Rank-based predictors for resp ...... chemotherapy in breast cancer.
@nl
P2093
P2860
P1476
Rank-based predictors for resp ...... chemotherapy in breast cancer.
@en
P2093
Chunxiang Hao
Chunyang Liu
Guini Hong
Hongdong Li
Xianxiao Zhou
P2860
P2888
P304
P356
10.1007/S10549-013-2566-2
P407
P50
P577
2013-05-22T00:00:00Z